The announcement by the Therapeutic Goods Administration that pharmaceutical products that contain codeine will no longer be available over the counter in 2018 has been met with resistance by the Australian Self Medication Industry and many ordinary Australians who rely on these medications for self-management of pain.
Medications containing codeine will be Schedule 4 drugs from February 2018, meaning that for people to obtain them, they will have to get a prescription from a GP.
Already a subscriber? Log in
Easter flash sale:
10 issues for $1
Subscribe this Easter and get the next 10 issues of the magazine, plus website and app access, all for just $1.
- Weekly delivery of the magazine
- Unlimited access to spectator.com.au and app
- Spectator Australia podcasts and newsletters
- Full access to spectator.co.uk
Comments
Easter flash sale: 10 issues for $1
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
CLAIM OFFER 10 issues for $1Already a subscriber? Log in